Displaying 69 out of 2,424 Health Tech companies
 Filter
City
Country
Stage
Business Model
Industry
company score funding investors employees industries biz model city contact
Pheon Therapeutics HIRING

Antibody-Drug Conjugate specialist creating treatments for tough-to-treat cancers.

79
$120M · Series B TCG Crossover, Atlas Ventures, Brandon Capital 11 to 50 Health Tech, Biotech, Deep Tech, Pharma B2B London, UK •••••••••••@pheontx.com
SynOx Therapeutics HIRING

Developer of treatment for diffuse tenosynovial giant cell tumors.

68
$75M · Series B Bioqube Ventures, Medicxi, Forbion Capital Partners 1 to 10 Health Tech, Biotech B2B Dublin, Ireland •••••••••••@synoxtherapeutics.com
Tubulis

Developer of chemotherapeutic drugs designed to fight against cancer and chronic diseases.

68
$139M · Series B Nextech Invest, EQT Life Sciences, Andera Partners 11 to 50 Health Tech, Biotech, Deep Tech B2B Munich, Germany •••••••••••@tubulis.com
CN BioJUST ADDED HIRING

Provider of single and multi-organ microphysiological systems.

68
$21M · Series B CN Innovations 101 to 250 Health Tech, Biotech London, UK •••••••••••@cn-bio.com
Causaly

Biomedical research discovery tool.

64
$60M · Series B ICONIQ Growth, Index Ventures, Pentech Ventures 51 to 100 Health Tech, AI, Biotech, Pharma B2B, SaaS London, UK •••••••••••@causaly.com
GetHarley

Skin care telehealth platform.

64
$52M · Series B Village Global, Index Ventures, Headline 101 to 250 Health Tech B2C London, UK •••••••••••@getharley.com
Beacon Therapeutics

Oophthalmic gene therapy company to treat blinding retinal illnesses.

64
$120M · Series A Syncona Partners LLP 1 to 10 Health Tech, Biotech London, UK •••••••••••@beacontx.com
Eligo Bioscience

Gene-editing platform.

64
$30M · Series B Khosla Ventures, Sanofi Ventures, Bpifrance 11 to 50 Health Tech, Biotech Paris, France •••••••••••@eligo.bio
HEPHAISTOS-Pharma HIRING

Immunotherapies developer for cancer patient.

64
$4M · Seed Fournier-Majoie, France 2030, Elaia 1 to 10 Health Tech, Biotech Paris, France •••••••••••@hephaistos-pharma.fr
Sorella Care

Digital health platform for women.

64
$5M · Seed Blisce, Vorwerk Ventures 1 to 10 Health Tech B2C, SaaS Paris, France •••••••••••@sorella-care.com
Flindr TherapeuticsJUST ADDED HIRING

Precision oncology treatments developer.

64
$21M · Series A V-Bio Ventures 1 to 10 Health Tech, Biotech Amsterdam, Netherlands •••••••••••@flindrtx.com
KlineoJUST ADDED HIRING

AI-based platform for clinical trials.

64
$2M · Seed Pfizer Healthcare Hub: London, Bpifrance, Wilco 1 to 10 Health Tech, AI B2B, SaaS Paris, France •••••••••••@klineo.fr
Captain T CellJUST ADDED HIRING

Developer of next-generation T cells against solid tumors.

64
$9M · Seed Brandenburg Kapital, i&i Biotech Fund 1 to 10 Health Tech, Biotech Berlin, Germany •••••••••••@captaintcell.com
Automata

Workflow automation platform for the life sciences industry.

59
$40M · Series B Local Globe, Dimension, Hummingbird Ventures 51 to 100 Health Tech, Machine Learning B2B London, UK •••••••••••@automata.tech
Cera

Technology-enabled company providing home care services in London.

59
$64M Oltre Venture 5001 to 10000 Health Tech, Mobile, Service Industry, ElderTech B2B, B2C London, UK •••••••••••@ceracare.co.uk
CorWave

Innovative heart pumps manufacturer.

59
$28M · Series C Bpifrance, Sofinnova Partners, Ysios Capital 51 to 100 Health Tech, Hardware B2B Paris, France •••••••••••@corwave.com
Gleamer

AI software for radiologists.

59
$29M · Series B Bpifrance, Heal Capital, Elaia 1 to 10 Health Tech, AI B2B Paris, France •••••••••••@gleamer.ai
Lassie

Digital pet insurance platform.

59
$25M · Series B Balderton Capital, Felix Capital, Inventure 1 to 10 Health Tech, Pet Tech B2C, Marketplace Stockholm, Sweden •••••••••••@lassie.co
Mnemo Therapeutics

Biotechnology firm focused on life science advancements.

59
$89M · Series A Sofinnova Partners 101 to 250 Health Tech, Biotech B2B Paris, France •••••••••••@mnemo-tx.com
Moon Surgical

Robots for surgery.

59
$55M · Series B Sofinnova Partners, Cathay Innovation 11 to 50 Health Tech, Hardware, Deep Tech, Robotics, Manufacturing B2B Paris, France •••••••••••@moonsurgical.com
Orbis Medicines

Oral macrocycle drug discovery platform.

59
$28M · Seed Novo A/S, Forbion Capital Partners 1 to 10 Health Tech, Biotech B2B Copenhagen, Denmark •••••••••••@orbismedicines.com
Oxford Medical Simulation

Virtual reality healthcare training platform.

59
$12M · Series A Frog Capital, ACF Investors, QVentures 1 to 10 Health Tech, Edtech B2B, SaaS London, UK •••••••••••@oxfordmedicalsimulation.com
Payfit

Platform enabling small and medium enterprises to effortlessly pay their employees.

59
$79M · Series C Accel, Eurazeo 251 to 500 Health Tech B2B, SaaS Paris, France •••••••••••@payfit.com
Pixacare HIRING

AI-powered wound care monitoring platform.

59
$3M · Seed Bpifrance, Elaia, 50 Partners 11 to 50 Health Tech B2B, SaaS Paris, France •••••••••••@pixacare.com
SparingVision

Biotechnology company focused on developing genomic medicines to treat blinding inherited retinal diseases.

59
$52M · Series A Ysios Capital 1 to 10 Health Tech, Biotech, Deep Tech B2B Paris, France •••••••••••@sparingvision.com
Withings

Developer of digital health and wellness devices like fitness trackers and watches.

59
$60M · Series B 2050 101 to 250 Health Tech, Hardware, Sportstech, Mobile, Manufacturing, Wearables B2B Paris, France •••••••••••@withings.com
Neko Health

Preventative health care platform.

59
$65M · Series A General Catalyst, Atomico, Lakestar 11 to 50 Health Tech B2C Stockholm, Sweden •••••••••••@nekohealth.com
Basecamp Vascular

Mechatronic guidewires manufacturer.

59
$6M · Series A Forepont Capital Partners, NTI Corporation 11 to 50 Health Tech, Hardware B2B Paris, France •••••••••••@basecampvascular.com
Luma Vision

4D cardiac imaging and navigation platform.

59
$21M · Series A EIC Accelerator, EQT Life Sciences, Atlantic Bridge University Fund 11 to 50 Health Tech B2B, SaaS Dublin, Ireland •••••••••••@lumavision.com
IMU Biosciences

AI platform to map the human immune system.

59
$14M · Series A Life Extension Ventures, Molten Ventures 11 to 50 Health Tech, Biotech London, UK •••••••••••@imubiosciences.com
MIP Discovery

Developer of non-biological affinity reagents to accelerate the production of cell and gene therapies.

59
$8M · Series A Mercia Asset Management 11 to 50 Health Tech, Biotech London, UK •••••••••••@mipdiscovery.com
MetyosJUST ADDED

Biosensors developer to combat chronic kidney disease.

59
$2M · Pre Seed Bpifrance, Kima Ventures, Cenitz 1 to 10 Health Tech, Biotech Paris, France •••••••••••@metyos.com
NeurosterixJUST ADDED

Advanced allosteric modulator therapeutics developer for neurological disorders.

59
$63M · Series A Xontogeny, Perceptive Advisors, Acorn Bioventures 1 to 10 Health Tech, Biotech Geneva, Switzerland •••••••••••@neurosterix.com
NeurocareJUST ADDED HIRING

Digital therapy platform for mental health treatment.

59
$17M · Series A TVM Capital Healthcare 101 to 200 Health Tech B2C, SaaS Munich, Germany •••••••••••@neurocaregroup.com
VertigeniusJUST ADDED HIRING

Wearable head sensor maker for vertigo treatment.

59
$2M · Seed Atlantic Bridge 1 to 10 Health Tech, Manufacturing B2C Dublin, Ireland •••••••••••@vertigenius.com
En Carta DiagnosticsJUST ADDED HIRING

Point-of-care diagnostic platform.

59
$1M · Pre Seed CentraleSupélec Venture 1 to 10 Health Tech, Biotech Paris, France •••••••••••@encarta.bio
Carrick Therapeutics

Clinical-stage biopharmaceutical company.

54
$95M · Series A Lightstone, GV, ARCH Venture Partners 51 to 100 Health Tech, Deep Tech B2C Dublin, Ireland •••••••••••@carricktherapeutics.com
CarThera

Ulltrasound-based medical devices manufacturer to treat various brain disorders.

54
$4M · Series B Unorthodox Ventures, EIC Accelerator, Panakes Partners 1 to 10 Health Tech, Hardware B2C Paris, France •••••••••••@carthera.eu
CatalYm

Innovative immunotherapies developer for cancer patients.

54
$51M Forbion Capital Partners, Vesalius Biocapital Partners, Bayern Kapital 11 to 50 Health Tech, Biotech, Manufacturing B2B Munich, Germany •••••••••••@catalym.com
Charm Therapeutics

Platform using deep learning on 3D molecular structures to develop treatments for harmful proteins.

54
$50M · Series A Khosla Ventures, General Catalyst 1 to 10 Health Tech, AI, Biotech, Data and Analytics B2B London, UK •••••••••••@charmtx.com
Corti

AI-driven services that aid healthcare providers in delivering timely, accurate care.

54
$60M · Series B Atomico, Eurazeo, Prosus & Naspers 51 to 100 Health Tech, Machine Learning B2B, SaaS Copenhagen, Denmark •••••••••••@corti.ai
Egle Therapeutics

Biotechnology firm developing immunotherapies for cancer and autoimmune diseases.

54
$46M Bioqube Ventures 11 to 50 Health Tech, Biotech B2B Paris, France •••••••••••@egle-tx.com
Entia

At-home blood testing platform for cancer patients.

54
$17M · Series A Business Growth Fund, Parkwalk Advisors 11 to 50 Health Tech B2B London, UK •••••••••••@entia.co
Eyevensys

Platform that develops bio factories to treat significant eye diseases sustainably.

54
$30M · Series B Karista, Pureos Bioventures 11 to 50 Health Tech, Hardware, Biotech, Manufacturing B2B Paris, France •••••••••••@eyevensys.com
Fertifa

Fertility treatment for employees.

54
$6M · Seed Notion Capital, Passion Capital, Tiny VC 1 to 10 Health Tech B2B London, UK •••••••••••@fertifa.com
Habyt

Community-driven living spaces designed and managed with technology and aesthetic appeal.

54
$45M · Series C High Rise Ventures, HV Capital, Deutsche Invest Equity Partners 11 to 50 Health Tech, Proptech & Real Estate, Community & Lifestyle B2B, B2C Berlin, Germany •••••••••••@habyt.com
Hublo

Software that simplifies daily tasks for healthcare professionals, allowing them to focus on patient care.

54
$25M · Series A Revaia, Acton Capital 51 to 100 Health Tech B2B, SaaS Paris, France •••••••••••@hublo.com
Huma

Digital health platform for predictive care and research.

54
$25M · Series B Unilever Ventures, Samsung NEXT 101 to 250 Health Tech, Data and Analytics, Business Intelligence B2B, SaaS London, UK •••••••••••@huma.com
Kheiron

We’re going where no-one has ever gone before. -- We’re fighting cancer. -- Lives are at stake.

54
$22M · Series A Hoxton Ventures, Atomico, Connect Ventures 11 to 50 Health Tech, AI B2B London, UK •••••••••••@kheironmed.com
Lifen

Platform for simple and secure exchange of medical letters.

54
$22M · Series B Daphni, Partech Ventures, Serena 11 to 50 Health Tech, Hardware B2B, SaaS Paris, France •••••••••••@lifen.fr
Lindus Health

Clinical trials platform.

54
$18M · Series A Valar Ventures, Creandum, Seedcamp 11 to 50 Health Tech, Biotech B2B, SaaS London, UK •••••••••••@lindushealth.com
MinervaX

Developer of prophylactic vaccine against Group B Streptococcus.

54
$57M · Series C EQT Partners, Novo A/S, OrbiMed 1 to 10 Health Tech, Biotech B2B Copenhagen, Denmark •••••••••••@minervax.com
Nabla

Digital care. Superpowered. Build engaging relationships with your patients through our machine learning-powered care platform.

54
$20M Firstminute Capital 11 to 50 Health Tech, AI, Mobile B2C Paris, France •••••••••••@nabla.com
Ori Biotech

Manufacturing platform designed to help patients access lifesaving treatments.

54
$30M · Series A Kindred Capital, Octopus Ventures, Amadeus Capital 1 to 10 Health Tech, Biotech, Manufacturing B2B London, UK •••••••••••@oribiotech.com
Ouihelp

Online platform providing residential assistance for seniors to help with daily activities at home.

54
$31M · Series B Future Positive Capital, XAnge 51 to 100 Health Tech B2B, B2C, Marketplace Paris, France •••••••••••@ouihelp.fr
Oviva

Behavior change platform digitizing the treatment of type 2 diabetes and obesity.

54
$21M · Series B Earlybird Venture Capital, AlbionVC, Partech Ventures 251 to 500 Health Tech, Foodtech, CPG & Consumer Goods, Ecommerce B2B London, UK •••••••••••@oviva.com
Quell Therapeutics

Cell therapy firm specializing in developing treatments using advanced cellular technology.

54
$45M · Series A AlbionVC, Point72 Ventures 101 to 250 Health Tech, Edtech, Biotech, Manufacturing B2B London, UK •••••••••••@quell-tx.com
Recare

Platform optimizing clinical pathways between hospitals, care providers, and payers for better discharge management.

54
$3M · Seed Gilion 51 to 100 Health Tech B2B, SaaS Berlin, Germany •••••••••••@recaresolutions.com
Reshape Biotech

Lab automation robots manufacturer.

54
$20M · Series A R7 Partners, ACME Capital, Y Combinator 11 to 50 Health Tech, Robotics B2B Copenhagen, Denmark •••••••••••@reshapebiotech.com
ReViral

Biotechnology firm developing antiviral treatments for patients.

54
$44M · Series C Novo A/S, Andera Partners 11 to 50 Health Tech, Biotech, Pharma B2B London, UK •••••••••••@reviral.co.uk
SafeHeal

Solution for protecting digestive anastomosis, designed to reduce complications.

54
$47M Sofinnova Partners 1 to 10 Health Tech, Hardware, Pharma, Manufacturing B2B Paris, France •••••••••••@safeheal.com
Sekoia

Cybersecurity platform.

54
$37M · Series A Northcap 101 to 250 Health Tech, Hardware, Cybersecurity, Manufacturing B2B, SaaS Paris, France •••••••••••@sekoia.io
Sonio

AI-powered prenatal screening solution.

54
$14M · Series A Bpifrance, Elaia, EIC Accelerator 11 to 50 Health Tech, Deep Tech SaaS Paris, France •••••••••••@sonio.ai
Sooma

Device providing non-invasive brain stimulation for treating depression and chronic pain.

54
$5M · Series A Verge HealthTech Fund, Voima Ventures 1 to 10 Health Tech Helsinki, Finland •••••••••••@soomamedical.com
Teale

Digital mental health platform for employees.

54
$10M · Series A Bpifrance, Kima Ventures, Alter Equity 3P 1 to 10 Health Tech B2B, SaaS Paris, France •••••••••••@teale.io
Tilak Healthcare

Remote monitoring system for ophthalmic conditions.

54
$10M · Series A Elaia, iBionext, Cap Horn 11 to 50 Health Tech B2C Paris, France •••••••••••@tilakhealthcare.com
Wandercraft

Exoskeleton enabling self-balanced walking for inpatient rehabilitation and daily outpatient use.

54
$45M · Series C XAnge 51 to 100 Health Tech, Hardware, Deep Tech, Robotics, Manufacturing B2B Paris, France •••••••••••@wandercraft.eu
Wellola

Platform connecting clinics with their clients, anywhere, anytime.

54
$2M · Seed Bay Advisory, Elkstone, Enterprise Ireland 1 to 10 Health Tech, Fintech, Video, Payments, Communications B2B, SaaS Dublin, Ireland •••••••••••@wellola.com
Hypervision Surgical

Precision software for eye surgery.

54
$8M · Seed Redalpine 1 to 10 Health Tech, Biotech London, UK •••••••••••@hypervisionsurgical.com

Seedtable’s take on Health Tech

By Gonz Sánchez Sarmiento
CEO at Seedtable

Health Tech in Europe is a rapidly growing industry that is transforming medicine. Some of the trends powering this transformation include AI in healthcare, an increased focus on patient data, staff wellness, remote healthcare, and wearables. However, Europe is facing substantial challenges in continuing to deliver high-quality healthcare services to its citizens, including ageing populations, cultural shifts, rigid and complex financing models, increasing costs of innovation, a scarcity of skilled personnel, rising health inequalities, and health complexities stemming from climate change. The European Union has implemented the Regulation on Health Technology Assessment (HTA) to improve the quality of HTA across the Union and ensure an efficient use of resources. The European digital health market is predicted to grow at a CAGR of 27.1% from 2020 to 2025, with the UK, Germany, and France being the largest markets. The use of data and technology in the healthcare and life sciences sectors is expected to continue to enhance the industry, with artificial intelligence and machine learning playing a central role. However, the industry is fragmented, especially when it comes to rules and operational standards across the continent, making it challenging to establish a legal basis to allow the exchange of health data.

OTHER INDUSTRIES
Other Health Tech startups by location